Dr. Sravan Panuganti

Dr. Sravan Panuganti
Dr. Panuganti is a native of New Jersey where he was born and raised. He completed his college education at the University of Pittsburgh. He then went on to medical school at the Philadelphia College of Osteopathic Medicine. He completed his residency in urological surgery at Jefferson New Jersey Hospitals in Southern New Jersey followed by a fellowship in Men's Sexual Medicine at MD Anderson Cancer Center and University of Texas Health Science Center in Houston, TX. He is an Assistant Professor in Urology at the Virginia College of Osteopathic Medicine- Carolinas Campus in Spartanburg, SC. He is a fellow of the American College of Osteopathic Surgeons. His speciality interests in urology include benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). He believes in early intervention for BPH and is trained in a variety of treatment options. He lives in Charlotte with his wife, two kids and dog.
Medical School:

Philadelphia College of Osteopathic Medicine


Jefferson University Hospitals- New Jersey (formerly Rowan University)


MD Anderson Cancer Center / University of Texas Health Science Center- Houston


University of Pittsburgh

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only